Home > Boards > US Listed > Biotechs >

Progenics Pharmaceuticals Inc. (PGNX)

PGNX RSS Feed
Add PGNX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 10/10/2019 3:06:16 PM - Followers: 64 - Board type: Free - Posts Today: 0

http://www.progenics.com/

http://finance.yahoo.com/q/ks?s=PGNX

Progenics Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutic products for the treatment of unmet medical needs of patients with debilitating conditions and life-threatening diseases in the United States. It primarily focuses on the areas of gastroenterology, virology, and oncology. The company's development programs and product candidates include methylnaltrexone-subcutaneous, which completed Phase 3 clinical trial for the treatment of opioid-induced constipation; methylnaltrexone-intravenous, which is under Phase 3 clinical trial for the management of post-operative ileus; and Methylnaltrexone-Oral, a Phase 2 clinical trial oral form for the treatment of opioid-induced constipation. It is also developing PRO 140 Phase 1b clinical trial, designed to block HIV infection by inhibiting virus-cell binding; ProVax, a vaccine product candidate for the prevention of HIV infection or therapeutic treatment for HIV-positive individuals; and GMK Vaccine, a therapeutic vaccine, which is in Phase 3 clinical trial for the prevention of recurrence of melanoma. In addition, the company engages in a research program to discover treatments for hepatitis C, a chronic liver disease that block viral entry into cells. Further, Progenics Pharmaceuticals, through a joint venture with Cytogen Corporation, is developing in vivo immuno-therapies for treatment of prostate cancer, including a human monoclonal antibody-drug conjugate directed against prostate-specific membrane antigen (PSMA). The company's PSMA vaccine is in Phase 1 clinical testing. It has a collaboration agreement with Wyeth Pharmaceuticals to develop and commercialize subcutaneous, intravenous, and oral forms of methylnaltrexone. The company was incorporated in 1986 and is based in Tarrytown, New York.





 

PGNX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PGNX News: Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) 12:47 PM
PGNX News: Proxy Statement - Non-management (definitive, Revised) (dfrn14a) 10/11/2019 04:03:48 PM
PGNX News: Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) 10/10/2019 06:02:02 AM
PGNX News: Progenics Sends Letter to Shareholders 10/09/2019 04:30:00 PM
PGNX News: Proxy Statment - Contested Solicitations (definitive) (defc14a) 10/08/2019 04:26:06 PM
News News Alert: Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) 10/16/2019 12:47:29 PM
PostSubject
#781   LNTH is a trivial little company with no vinmantoo 10/10/19 03:06:15 PM
#780   * * $PGNX Video Chart 10-02-2019 * * ClayTrader 10/02/19 05:31:01 PM
#779   News: $PGNX Velan Comments on Announced Sale of whytestocks 10/02/19 04:50:24 PM
#778   News: $PGNX Progenics Merger Investigation: Halper Sadeh LLP whytestocks 10/02/19 04:40:29 PM
#777   News: $PGNX Why Lantheus Holdings Is Dropping Today whytestocks 10/02/19 04:30:20 PM
#776   News: $PGNX Lantheus to Acquire Progenics to Form whytestocks 10/02/19 04:24:25 PM
#775   They are selling the company at market price:) vinmantoo 10/02/19 12:53:50 PM
#774   They are selling the company at market price:) akocaman 10/02/19 09:15:00 AM
#773   Quote: Progenics Shareholders to Receive 0.2502 Shares of Lantheus MegaDeath 10/02/19 08:06:52 AM
#772   What is the price? akocaman 10/02/19 07:55:42 AM
#771   Lantheus to Acquire Progenics to Form a Leading MegaDeath 10/02/19 07:48:39 AM
#770   * * $PGNX Video Chart 08-21-2019 * * ClayTrader 08/21/19 07:21:15 PM
#769   News: $PGNX ISS Supports Velan's Call for Change whytestocks 06/28/19 03:10:22 PM
#768   News: $PGNX Progenics Reiterates Targeted Directors' Indispensable Exper whytestocks 06/28/19 03:00:27 PM
#767   News: $PGNX Velan Clarifies Interactions with Progenics Pharmaceuticals' whytestocks 06/28/19 02:50:28 PM
#766   News: $PGNX Velan sets the Record Straight on vinmantoo 06/18/19 12:16:39 PM
#765   News https://www.otcmarkets.com/stock/PGNX/news/story?e&id=1379758 MegaDeath 06/18/19 09:14:01 AM
#764   News: $PGNX Velan sets the Record Straight on whytestocks 06/17/19 04:40:45 PM
#763   And sell off 8.50 because....Well, we will... Zilla 05/24/19 01:16:00 AM
#762   We'll get there eventually be patient saturnz 05/06/19 09:11:54 PM
#761   Time's up! heyyou2 05/06/19 07:58:37 PM
#760   Im projecting about $8 pps in 2 weeks saturnz 04/24/19 03:06:58 PM
#759   https://www.marketwatch.com/story/like-amazon-these-stocks-have-100-buy-ratings- MegaDeath 04/24/19 01:30:20 PM
#758   More good news. mov1es 04/24/19 12:00:09 PM
#757   News https://www.otcmarkets.com/stock/PGNX/news/story?e&id=1338688 MegaDeath 04/24/19 09:03:59 AM
#756   This is a winner saturnz 04/22/19 01:04:28 PM
#755   Read something interesting in the 10k. PGNX Bored Lawyer 02/07/19 10:41:11 PM
#754   Relistor sales were up 88% over Q3 of vinmantoo 11/09/18 12:05:27 AM
#753   Relistor sales were up 88% over Q3 of vinmantoo 11/09/18 12:05:25 AM
#752   WOW what a head fake after ER. Took Zilla 11/08/18 03:17:01 PM
#751   75 million already done the same day... vinmantoo 10/14/18 06:23:24 PM
#750   75 million already done the same day... Zilla 10/14/18 04:57:40 PM
#749   yes, horrible - plus the 2nd failed trial. finesand 10/14/18 03:50:26 PM
#748   Need to add a 250 million shelf offering vinmantoo 10/14/18 01:28:30 PM
#747   Need to add a 250 million shelf offering Zilla 10/14/18 12:55:47 AM
#746   It's not clear what the barrier to entry vinmantoo 09/20/18 11:37:57 AM
#745   It's not clear what the barrier to entry oc631 09/19/18 03:24:22 PM
#744   You should also mention that Azedra patents expire vinmantoo 09/19/18 02:15:49 PM
#743   oc631 - thank you, fair restriction finesand 09/18/18 11:15:15 PM
#742   You should also mention that Azedra patents expire oc631 09/18/18 08:55:59 PM
#741   PGNX Recent Events & Catalysts finesand 09/17/18 11:10:13 PM
#740   NCCN Guidelines have been updated with AZEDRA, the finesand 09/17/18 10:55:56 PM
#739   ron- 5/2 RELISTOR® Injection Protected from Generic Competition finesand 09/17/18 10:51:52 PM
#738   vinm- yes, the capital raise was top notch, finesand 09/17/18 10:47:46 PM
#737   PGNX Recent Events & Catalysts finesand 09/17/18 10:43:21 PM
#736   it looks like a really smart move now oc631 09/13/18 03:01:25 PM
#735   it looks like a really smart move now oc631 09/13/18 03:00:55 PM
#734   The first sale of Azedra triggers an $8M vinmantoo 09/13/18 11:37:15 AM
#733   I agree about this stock. Makes no sense. oc631 09/12/18 08:02:25 PM
#732   I agree about this stock. Makes no sense. vinmantoo 09/12/18 07:43:30 PM
PostSubject